Tang Capital Management’s Immunocore IMCR Stock Holding History

Tang Capital Management’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$84.1M	Hold	2,649,368	–	–	3.82%	13
2026 Q1	$79.9M	Buy	2,649,368 +20,830	+0.8%	+$674K	4.06%	13
2025 Q4	$91.2M	Buy	2,628,538 +322,930	+14%	+$11.4M	4.51%	8
2025 Q3	$83.8M	Buy	2,305,608 +200,000	+9%	+$6.79M	3.22%	7
2025 Q2	$66.1M	Buy	2,105,608 +189,900	+10%	+$5.9M	3.34%	4
2025 Q1	$56.8M	Buy	1,915,708 +360,108	+23%	+$10.8M	3.14%	7
2024 Q4	$45.9M	Buy	1,555,600 +450,000	+41%	+$14.2M	3.04%	7
2024 Q3	$34.4M	Buy	1,105,600 +700,000	+173%	+$25.5M	2.46%	8
2024 Q2	$13.7M	Hold	405,600	–	–	1.4%	24
2024 Q1	$26.4M	Hold	405,600	–	–	2.75%	7
2023 Q4	$27.7M	Hold	405,600	–	–	2.56%	10
2023 Q3	$21.1M	Hold	405,600	–	–	2.97%	9
2023 Q2	$24.3M	Hold	405,600	–	–	3.58%	5
2023 Q1	$20.1M	Hold	405,600	–	–	2.99%	9
2022 Q4	$23.1M	Hold	405,600	–	–	3.36%	8
2022 Q3	$19M	Buy	405,600 +20,000	+5%	+$953K	2.33%	13
2022 Q2	$14.4M	Hold	385,600	–	–	2.18%	15
2022 Q1	$11.5M	Buy	+385,600	New	+$9.73M	2.31%	12

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Tang Capital Management's IMCR Position: Q2 2026 in Review

Tang Capital Management held its Immunocore (IMCR) position steady in Q2 2026 at 2,649,368 shares worth $84.1M. The position accounts for 3.82% of the portfolio, ranked #13.

Tang Capital Management first reported a position in IMCR in Q1 2022 and has held it in 18 quarters since. The position peaked at $91.2M in Q4 2025. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Tang Capital Management held 2,649,368 shares of Immunocore worth $84.1M as of Q2 2026.
Tang Capital Management left its Immunocore share count unchanged in Q2 2026.
Immunocore made up 3.82% of Tang Capital Management's portfolio in Q2 2026, its #13 holding.
Tang Capital Management first reported a position in Immunocore in Q1 2022 and has held it in 18 quarters since.
Tang Capital Management's Immunocore position peaked at $91.2M in Q4 2025.
136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Tang Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.